x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Neurology Today in 5

Neurology Today

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

science & medicine medicine

All Episodes

04:59

Magnesium sulfate for cerebral palsy, novel gene...

Neurology Today in 5 ·

2025/01/02

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral palsy; a novel mRNA system for gene therapy for muscular dystrophies, and the perception of CTE and suicidality risk in retired NFL players.

en

05:20

Revised criteria for diagnosing MS, AI for...

Neurology Today in 5 ·

2024/12/19

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.

en

05:02

3-year outcomes for anti-NMDAR encephalitis, skin...

Neurology Today in 5 ·

2024/12/05

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.

en

04:40

Cardiovascular effects of antiseizure therapies,...

Neurology Today in 5 ·

2024/11/21

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer’s disease.

en

04:20

Fever prevention and stroke, environmental toxins and...

Neurology Today in 5 ·

2024/11/07

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on fever prevention and stroke outcomes, the impact of air pollution and other environmental toxins on Parkinson’s, and the role of cholesterol overload in ALS progression and disease risk.

en

04:41

Blood test for ALS, new migraine target reduces...

Neurology Today in 5 ·

2024/10/17

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder. This Podcast is being Sponsored by LocumTenens.com

en

04:32

Eastern equine encephalitis, systems for anti-amyloid...

Neurology Today in 5 ·

2024/10/03

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on Eastern equine encephalitis relief, systems developed to meet demand for anti-amyloid therapies, and a new protocol for timely diagnosis and treatment for eye stroke in the emergency department. This Podcast is being Sponsored by LocumTenens.com

en

04:46

Brain circuit underlying placebo pain relief, common...

Neurology Today in 5 ·

2024/09/19

In this week’s podcast, Neurology Today’s editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson’s gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer’s.

en

05:04

Alzheimer’s diagnosis criteria, AI and Parkinson’s...

Neurology Today in 5 ·

2024/09/05

In this week’s podcast, Neurology Today’s editor-in-chief highlights a new workgroup’s recommendations on biomarkers for diagnosing Alzheimer’s, AI’s ability to track Parkinson’s severity from brief videos, and the latest research on how racism leads to neural changes and accelerated aging.

en

05:22

Weight loss drugs and optic neuropathy, normothermic...

Neurology Today in 5 ·

2024/08/15

In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the association between weight loss drugs and a rare type of optic neuropathy, ethical issues around normothermic regional perfusion, and how neurologists are onboarding and training advanced practice practitioners in comorbid cancer and stroke.

en

05:12

Body composition and neurologic disease, Tenecteplase...

Neurology Today in 5 ·

2024/07/31

In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the complex interaction between body composition, vascular health, and neurodegenerative disease, Tenecteplase in an extended treatment window and stroke-related disability, and gene expression in cormorbid cancer and stroke.

en

05:17

Antihypertensive and reduced risk for epilepsy, first...

Neurology Today in 5 ·

2024/07/18

In this week’s podcast, Neurology Today’s editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.

en

05:10

Rescue therapies when endovascular thrombectomy...

Neurology Today in 5 ·

2024/07/04

In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI’s use in sleep neurology.

en

04:45

When to withdraw life support for severe TBI,...

Neurology Today in 5 ·

2024/06/20

In this week’s podcast, Neurology Today’s editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information

en

04:44

Code for ICH, new findings on Havana syndrome, distal...

Neurology Today in 5 ·

2024/06/06

In this week’s podcast, Neurology Today’s editor-in-chief discusses a push among neurocritical care experts to develop a code procedure for intracerebral hemorrhage, new findings showing people with Havana syndrome have functional neurologic disorder, and a study reporting distal symmetric polyneuropathy is more prevalent but less diagnosed in primary care clinics in low-income areas. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

en

04:54

Surgical removal of hematoma in ICH, disparities in...

Neurology Today in 5 ·

2024/05/16

In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study reporting better outcomes with surgical removal of hematoma in intracerebral hemorrhage, disparities in access to diagnosis and care for epilepsy, and the challenges that remain for women in neurology research.

en

04:48

Generative AI for personal statements, Match Day and...

Neurology Today in 5 ·

2024/05/02

Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors’ response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.

en

04:31

ME/CFS and long COVID; negative outcomes for ALS...

Neurology Today in 5 ·

2024/04/18

Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer’s disease.

en

04:24

BTK inhibitors for MS, lecanemab, neurologic adverse...

Neurology Today in 5 ·

2024/04/04

Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assessment of the cost-effectiveness of lecanemab, and findings that COVID vaccines are not significantly associated with adverse neurologic events.

en

04:38

SARS-CoV-2 and dopamine neurons, valproate risks for...

Neurology Today in 5 ·

2024/03/21

Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.

en

200 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事